A team from the Indian Institute of Technology Delhi has developed a topical treatment for mycotic keratitis with five times the corneal penetration of standard natamycin (pimaricin) treatment.
A deadly fungus infection has surged through India in recovering Covid-19 patients, many of whom have had an eye removed to prevent the fungus infecting the brain. Known as mucormycosis or ‘the
Two ambitious global eye health targets for 2030 were endorsed by 194 member states at the 74th World Health Assembly (WHA), in Geneva, Switzerland, but do not seem to have garnered much attention in New Zealand.
A Dutch study has demonstrated an association between some immune-system disorders and keratoconus (KC).
The RANZCO New Zealand Branch 2022 annual scientific meeting will take place at the Marlborough Convention Centre in Blenheim from Friday 22 to Saturday 23 April, with an evening welcome function on Thursday 21 April.
The Centre of Eye Research Australia (CERA) is encouraging Australia’s nurses to take part in a survey to get a snapshot of the workforce and shape the discussion about nurses’ involvement in
A Sydney Eye Hospital clinical trial is investigating the safety and efficacy of treating macular oedema with infrared light instead of the current mainstay eye injections. “Eye injections work very
A routine eye examination could allow doctors to detect long Covid in patients, according to a new study. Led by Dr Gulfidan Bitirgen from Necmettin Erbakan University, Turkey, the study included 40
The FDA has granted orphan drug designation to Aldeyra Therapeutics’ ADX-2191 (methotrexate for intravitreal injection) for the treatment of primary vitreoretinal lymphoma (PVRL). The US
A review of ophthalmology clinical trials resulting in FDA-approved drugs has found the majority failed to represent the USA’s ethnic makeup. Led by Dr Sean Berkowitz from Vanderbilt University
Researchers at the National Eye Institute (NEI), USA, have discovered that neurotrophic pigment epithelium-derived factor (PEDF) peptides act as neuronal guardians for the retina, highlighting their
Results from a new study show overwhelming support for artificial intelligence (AI) to improve the poor rates of diabetic retinopathy (DR) screening in New Zealand and significantly reduce the number of people with diabetes going blind unnecessarily.